We’re thrilled to announce that Dr. Hsing-Mao Chu, CEO of T-E Meds is honored to present at The 5th ADC Development Summit on March 1-2, 2024, in Suzhou, China.
Dr. Chu will unveil our revolutionary ADC platform, focusing on the proprietary “Multi- Arm Linkers,” which optimizes Drug-to-Antibody Ratios (DARs) and enables dual-
payload designs.
